ロード中...
Pioglitazone therapy in mouse offspring exposed to maternal obesity
OBJECTIVE: Pioglitazone (PIO), an antidiabetic drug of the thiazolidinedione family, improves glucose and lipid metabolism in muscle, adipose, and liver tissues via peroxisome proliferator-activated receptor gamma (PPARγ) activation. We hypothesize that PIO therapy will improve the metabolic status...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3610768/ https://ncbi.nlm.nih.gov/pubmed/23313309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2013.01.013 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|